Advanced search
Publication Cover
Hypertension in Pregnancy Volume 31, 2012 - Issue 1
Submit an article Journal homepage
321
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Angiopoietin-2: A Promising Indicator for the Occurrence of Severe Preeclampsia

Soo Yeon HanDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
, MD,
Jong Kwan JunDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
, MD,
Cha-Hui LeeDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
, MS,
Joong Shin ParkDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
, MD &
Hee Chul SynDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
, MD
Pages 189-199 | Published online: 23 Sep 2010

REFERENCES

  • Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: Linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9:147–160.
  • Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407(6801):242–248.
  • Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353–364.
  • Breier G, Damert A, Plate KH, Risau W. Angiogenesis in embryos and ischemic diseases. Thromb Haemost 1997; 78:678–683.
  • Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:4–25.
  • Maisonpierre PC, Suri C, Jones PF, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277(5322):55–60.
  • Wulff C, Weigand M, Kreienberg R, Fraser HM. Angiogenesis during primate placentation in health and disease. Reproduction 2003; 126:569–577.
  • Reynolds LP, Borowicz PP, Vonnahme KA, Animal models of placental angiogenesis. Placenta 2005; 26:689–708.
  • Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: Vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002; 87:4213–4224.
  • Tsatsaris V, Goffin F, Munaut C, Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. J Clin Endocrinol Metab 2003; 88:5555–5563.
  • Sgambati E, Marini M, Zappoli Thyrion GD, VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 2004; 111:564–570.
  • ACOG Committee on Practice Bulletins – ObstetricsACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99:159–167.
  • Zhang EG, Smith SK, Baker PN, Charnock-Jones DS. The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae. Mol Med 2001; 7:624–635.
  • Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004; 25:103–113.
  • Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996; 103:1191–1196.
  • Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost 2005; 94:1071–1076.
  • Hirokoshi K, Maeshima Y, Kobayashi K, Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Am J Hypertens 2005; 18:1181–1188.
  • Parikh SM, Mammoto T, Schultz A, Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46.
  • Roviezzo F, Tsigkos S, Kotanidou A, Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005; 314:738–744.
  • Levine RJ, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672–683.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.